National Vision Holdings raised its fiscal 2026 adjusted operating income guidance to $119-$139 million and its adjusted EPS guidance to between 94 cents and $1.09, as premium products and a higher-value customer mix offset weaker store traffic. In the second quarter of 2026, adjusted comparable store sales rose 2.2%, with a 7.1% increase in average ticket offsetting a 4.9% decline in traffic; the e-commerce replatform cut adjusted comparable sales by an estimated 150 basis points, and excluding that impact America's Best would have delivered slightly more than 4% growth. Management now expects fiscal 2026 adjusted comparable store sales growth of 3% to 5%, and the Zacks Consensus Estimate for 2026 EPS has risen 4.3% to 98 cents over the past 30 days, while the 2026 revenue consensus stands at $2.06 billion, up 3.8% from the year-ago reported figure. The company, which has a market capitalization of $1.37 billion and a long-term estimated earnings growth rate of 19.5% versus the industry's 10.5%, still faces rising costs, with second-quarter costs applicable to revenues up 60 basis points to 41.8% of net revenues, and heavy vendor concentration, as roughly 86% of fiscal 2025 lens expenditures came from one vendor and nearly 96% of contact lens expenditures were with three vendors. National Vision shares have fallen 25.8% over the past 12 months, compared with an 8.9% decline for the industry and a 16.5% rise for the S&P 500 composite.
National Vision Holdings IncRaised fiscal 2026 adjusted operating income and EPS guidance as premium products and higher-value customer mix offset softer traffic.
Globus Medical
Teleflex Incorporated
Veracyte Inc